The pan European Stoxx 600 closed with a gain of 1.38 per cent. The UK's FTSE 100 gained 0.91 per cent, Germany's DAX climbed 1.55 per cent, and France's CAC 40 ended up 2.29 per cent, while ...

After Takeda lost exclusivity of Vyvanse last year, the FDA approved generic versions of Vyvanse from 11 drugmakers, including U.S.-based drugmakers Mallinckrodt and Viatris, UK-based Hikma ...

The FDA approved generic versions of Vyvanse from 11 drugmakers, including U.S.-based drugmakers Mallinckrodt and Viatris, UK-based Hikma Pharmaceuticals, and Indian drugmaker Sun Pharmaceutical ...

The FDA approved generic versions of Vyvanse from 11 drugmakers, including U.S.-based drugmakers Mallinckrodt and Viatris, UK-based Hikma Pharmaceuticals, and Indian drugmaker Sun Pharmaceutical ...

Hikma Pharmaceuticals PLC HIK shares inched up 0.82% to £19.77 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0.35% ...

On Tuesday, Hikma Pharmaceuticals (OTC:HKMPY) Plc (LSE:HIK) (OTC:HKMPF) stock received an upgrade in its rating from Hold to Buy, along with an increase in its price target from GBP21.00 to GBP24.00.

Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for ...

The app is now live on the various app stores — we’ve found it on Google Play, LG’s app store, and the Amazon App Store (searching for it on Apple TV only returned the legacy Twitter app as ...

Aug 27 (Reuters) - Drug companies Jazz (JAZZ.O), opens new tab and Hikma (HIK.L), opens new tab must face claims that they schemed to delay a generic version of Jazz’s blockbuster narcolepsy ...